期刊文献+

唑来膦酸钠防治假体周围骨溶解的实验研究 被引量:1

Inhibitory effect of zoledronate sodium on periprosthetic osteolysis induced by polyethylene particles
下载PDF
导出
摘要 目的 :观察唑来膦酸钠对磨损颗粒诱导的大鼠假体周围骨溶解的影响及其作用机制。方法 :选用30只成年雄性SD大鼠,体重250~300 g,随机分3组,每组10只,分别为空白对照组、模型对照组和唑来磷酸钠组。空白对照组不作任何处理;模型对照组及唑来磷酸钠组行右侧股骨植入聚乙烯颗粒和钛棒制备聚乙烯颗粒诱导假体周围骨溶解大鼠模型,术后唑来膦酸钠组每周皮下注射唑来磷酸钠0.1 mg/kg,连续用药8周后取血、处死并采集右侧股骨标本。测定各组股骨骨密度(BMD)、IL-1β、IL-6、TNF-α及血清TRAP5b、CTX-Ⅰ的含量。结果:与模型对照组比较:唑来膦酸钠组大鼠股骨骨密度增高,IL-1β、IL-6、TNF-α含量均下降;唑来膦酸钠组大鼠血清TRACP5b、CTX-Ⅰ水平降低。结论:唑来膦酸钠组能够有效抑制聚乙烯颗粒诱导的大鼠假体周围骨溶解,可能是通过抑制破骨细胞的活性及IL-1β、IL-6、TNF-α等细胞因子的表达实现,为临床防治人工关节假体周围骨溶解提供理论基础。 Objective:To observe the effect and mechanisim of zoledronate sodium on periprosthetic osteolysis in rat induced by polyethylene particles. Methods:Total 30 adult male SD rats,weighting from 250 to 300 g,were selected and randomly divided into three groups:blank control group,model control group and zoledronate sodium group respectively,10 animals for each group. No treatment was performed in the blank control group. In model control group and zoledronate sodium group,the modle of periprosthetic osteolysis in rats were made by implanting polyethylene particles and titanium rods into their right femurs. After operation,rats in zoledronate sodium group were administered with zoledronate sodium(0.1 mg / kg each week) through subcutaneous injection for 8 weeks,then the blood was obtained and all experimental animals were sacrificed to get the right femur specimens. The femur BMD,IL-1β,IL-6,TNF-α,serum TRACP5 b and CTX-Ⅰwere detected. Results:Compared with the model control group,the femur BMD was increased,while IL-1β,IL-6 and TNF-α were all decreased in zoledronate sodium group; the serum TRACP5 b and CTX- Ⅰlevel were both reduced in zoledronate sodium group. Conclusion:The zoledronate sodium could effectively inhibit periprosthetic osteolysis in rats induced by polyethylene particles,which might be realized by inhibiting the activity of osteoclasts and the expression of IL-1 β,IL-6 and TNF-α. It provides a new method to treat periprosthetic osteolysis of the artificial joint prosthesis.
出处 《中国骨伤》 CAS 2015年第10期936-939,共4页 China Journal of Orthopaedics and Traumatology
基金 高等学校博士学科点专项科研基金资助课题(编号:20133322120004) 浙江省医药卫生科技计划项目(编号:2013KYA143) 浙江省自然科学基金资助项目(编号:LY12H27013)~~
关键词 大鼠 唑来膦酸钠 聚乙烯颗粒 破骨细胞 骨溶解 Rat Zoledronate sodium Polyethylene particle Osteoclast Osteolysis
  • 相关文献

参考文献16

  • 1Roato I,Caldo D,D\'Amico L,et al. Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues[J]. Biomaterials,2010,31(29):7519-7525.
  • 2Black DM,Reid IR,Boonen S,et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis:a randomized extension to the HORIZON-Pivotal Fracture Trial(PFT)[J]. J Bone Miner Res,2012,27(2):243-254.
  • 3Nishisho T,Hanaoka N,Miyagi R,et al. Local administration of zoledronic acid for giant cell tumor of bone[J]. Orthopedics,2015,38(1):e25-e30.
  • 4Piper PK Jr,Gruntmanis U. Management of osteoporosis in the aging male:focus on zoledronic acid[J]. Clin Interv Aging,2009,4:289-303.
  • 5Goodman SB,Gibon E,Yao Z. The basic science of periprosthetic osteolysis[J]. Instr Course Lect,2013,62:201-206.
  • 6García-López S,Villanueva R,Meikle MC. Alterations in the synthesis of IL-1β,TNF-α,IL-6,and their downstream targets RANKL and OPG by mouse calvarial osteoblasts in vitro:inhibition of bone resorption by cyclic mechanical strain[J]. Front Endocrinol(Lausanne),2013,4:160.
  • 7云帆,王瑞,赵建宁.破骨细胞的骨吸收机制[J].中国骨伤,2014,27(6):529-532. 被引量:25
  • 8Vasikaran S,Eastell R,Bruyère O,et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment:a need for international reference standards[J]. Osteopor- osis Int,2011,22(2):391-420.
  • 9Andersson G,Ek-Rylander B,Hollberg K,et al. TRACP as an oste- opontin phosphatase[J]. J Bone Miner Res,2003,18(10):1912-1915.
  • 10戴闽,程明,刘虎诚,程细高,范红先,张斌.不同浓度金属磨损颗粒对破骨细胞体外分化的影响[J].中国矫形外科杂志,2011,19(4):316-319. 被引量:11

二级参考文献142

  • 1戚孟春,胡静,邹淑娟,韩力赤,罗恩.大鼠骨髓间充质干细胞和颅骨成骨细胞在张应力下细胞骨架的改变[J].华西口腔医学杂志,2005,23(2):110-112. 被引量:24
  • 2程涛,戴闽,范红先,刘虎诚,郝亮,程细高.氧化铝陶瓷和高分子聚乙烯颗粒诱导体内生物学效应和细胞凋亡的研究[J].中华实验外科杂志,2007,24(1):113-113. 被引量:14
  • 3程涛,戴闽,韦金忠,郝亮,程细高,姚浩群,帅浪.无菌性松动全髋关节假体周围界膜组织中Caspase-3表达和细胞凋亡的研究[J].中国修复重建外科杂志,2007,21(8):810-813. 被引量:16
  • 4Cobb AG, Schmalzreid TP. The clinical significance of metalion release from cobalt-chromium metal-on-metal hip joint arthro plasty [ J ]. Proclnst Mech Eng,2006 ,2 :385 - 398.
  • 5Battaglino R, Kim D, Fu J, et al. C-mye is required for osteoclast differentiation[ J]. J Bone Miner Res,2002,5:763 - 773.
  • 6Hsu H, Lacey D, Dunstan C,et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation inducedby osteoprotegerin ligand[ J]. Proc Natl Acad Sci USA, 1999,7: 3540 - 3545.
  • 7Yamamoto A, Miyazaki T, Kadono Y, et al. Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand [ J ]. J Bone Miner Res, 2002,4:612 - 621.
  • 8Mizukami J, Takaesu G, Akatsuka H, et al. Receptor activator of NfkappaB ligand (RANKL) activates TAK1 mitogen-aetivated protein kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6 [ J ]. Mol Cell Biol, 2002,4 : 992 - 1000.
  • 9Shadduek RK, Waheed A, Mangan KF, et al. Preparation of a monoclonal antibody directed against the receptor for murine colony-stimulating factor - 1 [ J ]. Exp Hematol, 1993,4:515 - 520.
  • 10Koscki T ,Gao Y ,Okahashi N ,et al. Role of TGF - beta family in osteoclastogenesis induced by RANKL[ J]. Cell Signal ,2002,1 : 31 - 36.

共引文献52

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部